Patients enrolled in Medicare have seen savings on some out-of-pocket prescription costs for moderately priced drugs under ...
Rosnilimab demonstrated significant activity in T and B cells in patients with rheumatoid arthritis, targeting the ...
Every ophthalmologist will see patients with migraine, and in some cases, the ophthalmologist may be the first doctor ...
AI-interpreted transthoracic echocardiography reports were noninferior to human interpretations and may substantially cut ...
The FDA is requiring manufacturers of GLP-1 receptor agonist therapies to include warnings regarding the risk for ...
In this video, Wenxin (Vincent) Xu, MD, discussed the use of KIM-1 as a biomarker to select a treatment regimen in patients ...
Adults with moderate to severe obstructive sleep apnea and overweight or obesity who used the oral GLP-1 orforglipron for 1 ...
A 59-year-old man with a medical history of nasopharyngeal carcinoma, prediabetes, hyperlipidemia and hypothyroidism was ...
Survodutide, a novel glucagon/GLP-1 dual agonist, was noninferior to placebo for major adverse cardiovascular events, ...
To keep up with COPD research and care developments, the 2027 Global Initiative for Chronic Obstructive Lung Disease report ...
Obexelimab bested placebo in reducing glucocorticoid toxicity at 52 weeks among a cohort of patients with IgG4-related ...
Implementation of long-acting injectables for HIV care is still lacking important administrative and financial infrastructure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results